A 10-12 week multicenter, double-blind study to evaluate the efficacy and safety of the combination of valsartan (320mg) and simvastatin (80mg) compared to valsartan (320mg) and simvastatin (80mg) monotherapies in essential hypertension and hypercholesterolemia

Trial Profile

A 10-12 week multicenter, double-blind study to evaluate the efficacy and safety of the combination of valsartan (320mg) and simvastatin (80mg) compared to valsartan (320mg) and simvastatin (80mg) monotherapies in essential hypertension and hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Simvastatin; Valsartan
  • Indications Essential hypertension; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Sep 2008 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top